-
1
-
-
0035753424
-
FRA3B and other common fragile sites: The weakest links
-
K. Huebner, and C.M. Croce FRA3B and other common fragile sites: the weakest links Nat. Rev. Cancer 1 2001 214 221
-
(2001)
Nat. Rev. Cancer
, vol.1
, pp. 214-221
-
-
Huebner, K.1
Croce, C.M.2
-
3
-
-
0021690129
-
Constitutive fragile sites and cancer
-
J. Yunis, and A.L. Soreng Constitutive fragile sites and cancer Science 226 1984 1199 1204
-
(1984)
Science
, vol.226
, pp. 1199-1204
-
-
Yunis, J.1
Soreng, A.L.2
-
4
-
-
0028109387
-
Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B
-
F.L. Boldog, B. Waggoner, T.W. Glover, I. Chumakov, D. Le Paslier, and D. Cohen Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B Genes Chromosomes Cancer 11 1994 216 221
-
(1994)
Genes Chromosomes Cancer
, vol.11
, pp. 216-221
-
-
Boldog, F.L.1
Waggoner, B.2
Glover, T.W.3
Chumakov, I.4
Le Paslier, D.5
Cohen, D.6
-
5
-
-
0028169985
-
Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma
-
C.M. Wilke, S.W. Guo, B.K. Hall, F. Boldog, R.M. Gemmill, and S. Chandrasekharappa Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma Genomics 22 1994 319 326
-
(1994)
Genomics
, vol.22
, pp. 319-326
-
-
Wilke, C.M.1
Guo, S.W.2
Hall, B.K.3
Boldog, F.4
Gemmill, R.M.5
Chandrasekharappa, S.6
-
6
-
-
0030201105
-
A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints
-
W. Paradee, C.M. Wilke, L. Wang, R. Shridhar, C.M. Mullins, and A. Hoge A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints Genomics 35 1996 87 93
-
(1996)
Genomics
, vol.35
, pp. 87-93
-
-
Paradee, W.1
Wilke, C.M.2
Wang, L.3
Shridhar, R.4
Mullins, C.M.5
Hoge, A.6
-
7
-
-
0018736628
-
Hereditary renal-cell carcinoma associated with a chromosomal translocation
-
A.J. Cohen, F.P. Li, S. Berg, D.J. Marchetto, S. Tsai, S.C. Jacobs, and R.S. Brown Hereditary renal-cell carcinoma associated with a chromosomal translocation N. Engl. J. Med. 301 1979 592 595
-
(1979)
N. Engl. J. Med.
, vol.301
, pp. 592-595
-
-
Cohen, A.J.1
Li, F.P.2
Berg, S.3
Marchetto, D.J.4
Tsai, S.5
Jacobs, S.C.6
Brown, R.S.7
-
8
-
-
13344279424
-
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
-
M. Ohta, H. Inoue, M.G. Cotticelli, K. Kastury, R. Baffa, and J. Palazzo The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers Cell 84 1996 587 597
-
(1996)
Cell
, vol.84
, pp. 587-597
-
-
Ohta, M.1
Inoue, H.2
Cotticelli, M.G.3
Kastury, K.4
Baffa, R.5
Palazzo, J.6
-
9
-
-
0030890750
-
Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene
-
D. Zimonjic, T. Druck, M. Ohta, K. Kastury, C.M. Croce, N.C. Popescu, and K. Huebner Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene Cancer Res. 57 1997 1166 1170
-
(1997)
Cancer Res.
, vol.57
, pp. 1166-1170
-
-
Zimonjic, D.1
Druck, T.2
Ohta, M.3
Kastury, K.4
Croce, C.M.5
Popescu, N.C.6
Huebner, K.7
-
10
-
-
15444345047
-
Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities
-
G. Sozzi, S. Tornielli, E. Tagliabue, L. Sard, F. Pezzella, and U. Pastorino Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities Cancer Res. 57 1997 5207 5212
-
(1997)
Cancer Res.
, vol.57
, pp. 5207-5212
-
-
Sozzi, G.1
Tornielli, S.2
Tagliabue, E.3
Sard, L.4
Pezzella, F.5
Pastorino, U.6
-
11
-
-
0038793721
-
Cancer and the FRA3B/FHIT fragile locus: It's a HIT
-
K. Huebner, and C.M. Croce Cancer and the FRA3B/FHIT fragile locus: it's a HIT Br. J. Cancer 10 2003 1501 1506
-
(2003)
Br. J. Cancer
, vol.10
, pp. 1501-1506
-
-
Huebner, K.1
Croce, C.M.2
-
12
-
-
0030001342
-
Evaluation of the FHIT gene in colorectal cancers
-
S. Thiagalingam, N.A. Lisitsyn, M. Hamaguchi, M.H. Wigler, J.K. Willson, and S.D. Markowitz Evaluation of the FHIT gene in colorectal cancers Cancer Res. 56 1996 2936 2939
-
(1996)
Cancer Res.
, vol.56
, pp. 2936-2939
-
-
Thiagalingam, S.1
Lisitsyn, N.A.2
Hamaguchi, M.3
Wigler, M.H.4
Willson, J.K.5
Markowitz, S.D.6
-
13
-
-
0031971241
-
An FHIT tumor suppressor gene?
-
M.M. Le Beau, H. Drabkin, T.W. Glover, R. Gemmill, F.V. Rassool, T.W. McKeithan, and D.I. Smith An FHIT tumor suppressor gene? Genes Chromosomes Cancer 21 1998 281 289
-
(1998)
Genes Chromosomes Cancer
, vol.21
, pp. 281-289
-
-
Le Beau, M.M.1
Drabkin, H.2
Glover, T.W.3
Gemmill, R.4
Rassool, F.V.5
McKeithan, T.W.6
Smith, D.I.7
-
14
-
-
0034161988
-
Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus
-
M. Mori, K. Mimori, T. Shiraishi, H. Alder, H. Inoue, and Y. Tanaka Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus Cancer Res. 60 2000 1177 1182
-
(2000)
Cancer Res.
, vol.60
, pp. 1177-1182
-
-
Mori, M.1
Mimori, K.2
Shiraishi, T.3
Alder, H.4
Inoue, H.5
Tanaka, Y.6
-
15
-
-
18444397159
-
Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: No correlation with p53 expression and apoptosis
-
A. Kitamura, K. Yashima, E. Okamoto, H. Andachi, A. Hosoda, and Y. Kishimoto Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis Oncology 61 2001 205 211
-
(2001)
Oncology
, vol.61
, pp. 205-211
-
-
Kitamura, A.1
Yashima, K.2
Okamoto, E.3
Andachi, H.4
Hosoda, A.5
Kishimoto, Y.6
-
16
-
-
0002571605
-
Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions
-
X.P. Hao, J.E. Willis, T.G. Pretlow, J.S. Rao, G.T. MacLennan, I.C. Talbot, and T.P. Pretlow Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions Cancer Res. 60 2000 18 21
-
(2000)
Cancer Res.
, vol.60
, pp. 18-21
-
-
Hao, X.P.1
Willis, J.E.2
Pretlow, T.G.3
Rao, J.S.4
MacLennan, G.T.5
Talbot, I.C.6
Pretlow, T.P.7
-
17
-
-
0033818623
-
Loss of Fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease
-
D.C. Connolly, D.L. Greenspan, R. Wu, X. Ren, R.L. Dunn, and K.V. Shah Loss of Fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease Clin. Cancer Res. 6 2000 3505 3510
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 3505-3510
-
-
Connolly, D.C.1
Greenspan, D.L.2
Wu, R.3
Ren, X.4
Dunn, R.L.5
Shah, K.V.6
-
18
-
-
0032533493
-
Loss of FHIT function in lung cancer and preinvasive bronchial lesions
-
G. Sozzi, U. Pastorino, L. Moiraghi, E. Tagliabue, F. Pezzella, and C. Ghirelli Loss of FHIT function in lung cancer and preinvasive bronchial lesions Cancer Res. 58 1998 5032 5037
-
(1998)
Cancer Res.
, vol.58
, pp. 5032-5037
-
-
Sozzi, G.1
Pastorino, U.2
Moiraghi, L.3
Tagliabue, E.4
Pezzella, F.5
Ghirelli, C.6
-
19
-
-
23244433750
-
Concordant loss of fragile gene expression early in breast cancer development
-
G. Guler, A. Uner, N. Güler, S.Y. Han, D. Iliopoulos, P. McCue, K. Huebner, Concordant loss of fragile gene expression early in breast cancer development, Pathol. Int. 8 (2005) 471-478.
-
(2005)
Pathol. Int.
, vol.8
, pp. 471-478
-
-
Guler, G.1
Uner, A.2
Güler, N.3
Han, S.Y.4
Iliopoulos, D.5
McCue, P.6
Huebner, K.7
-
20
-
-
0036481752
-
Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients
-
L. Pylkkanen, H. Wolff, T. Stjernvall, P. Tuominen, T. Sioris, and A. Karjalainen Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients Int. J. Oncol. 20 2002 285 290
-
(2002)
Int. J. Oncol.
, vol.20
, pp. 285-290
-
-
Pylkkanen, L.1
Wolff, H.2
Stjernvall, T.3
Tuominen, P.4
Sioris, T.5
Karjalainen, A.6
-
21
-
-
85047699495
-
Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers
-
V. Chizhikov, S. Chikina, A. Gasparian, I. Zborovskaya, E. Steshina, and G. Ungiadze Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers Oncogene 21 2002 2398 2405
-
(2002)
Oncogene
, vol.21
, pp. 2398-2405
-
-
Chizhikov, V.1
Chikina, S.2
Gasparian, A.3
Zborovskaya, I.4
Steshina, E.5
Ungiadze, G.6
-
22
-
-
0033152189
-
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas
-
S. Ingvarsson, B.A. Agnarsson, B.I. Sigbjornsdottir, J. Kononen, O.P. Kallioniemi, and R.B. Barkardottir Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas Cancer Res. 59 1999 2682 2689
-
(1999)
Cancer Res.
, vol.59
, pp. 2682-2689
-
-
Ingvarsson, S.1
Agnarsson, B.A.2
Sigbjornsdottir, B.I.3
Kononen, J.4
Kallioniemi, O.P.5
Barkardottir, R.B.6
-
23
-
-
0035887084
-
Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma
-
M. Mori, K. Mimori, T. Masuda, K. Yoshinaga, K. Yamashita, A. Matsuyama, and H. Inoue Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma Cancer Res. 61 2001 7379 7382
-
(2001)
Cancer Res.
, vol.61
, pp. 7379-7382
-
-
Mori, M.1
Mimori, K.2
Masuda, T.3
Yoshinaga, K.4
Yamashita, K.5
Matsuyama, A.6
Inoue, H.7
-
24
-
-
0037099669
-
The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers
-
B.C. Turner, M. Ottey, D.B. Zimonjic, M. Potoczek, W.W. Hauck, and E. Pequignot The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers Cancer Res. 62 2002 4054 4060
-
(2002)
Cancer Res.
, vol.62
, pp. 4054-4060
-
-
Turner, B.C.1
Ottey, M.2
Zimonjic, D.B.3
Potoczek, M.4
Hauck, W.W.5
Pequignot, E.6
-
26
-
-
0032145266
-
Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas
-
H. Tanaka, Y. Shimada, H. Harada, M. Shinoda, S. Hatooka, M. Imamura, and K. Ishizaki Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas Cancer Res. 58 1998 3429 3434
-
(1998)
Cancer Res.
, vol.58
, pp. 3429-3434
-
-
Tanaka, H.1
Shimada, Y.2
Harada, H.3
Shinoda, M.4
Hatooka, S.5
Imamura, M.6
Ishizaki, K.7
-
27
-
-
0035324425
-
5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer
-
S. Zochbauer-Muller, K.M. Fong, A. Maitra, S. lam, J. Goradts, and R. Ashfuq 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer Cancer Res. 61 2001 3581 3585
-
(2001)
Cancer Res.
, vol.61
, pp. 3581-3585
-
-
Zochbauer-Muller, S.1
Fong, K.M.2
Maitra, A.3
Lam, S.4
Goradts, J.5
Ashfuq, R.6
-
28
-
-
1642400575
-
Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma
-
R. Maruyama, K. Sugio, I. Yoshino, Y. Maehara, and A.F. Gazdar Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma Cancer 100 2004 1472 1477
-
(2004)
Cancer
, vol.100
, pp. 1472-1477
-
-
Maruyama, R.1
Sugio, K.2
Yoshino, I.3
Maehara, Y.4
Gazdar, A.F.5
-
29
-
-
0035893756
-
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features
-
R. Maruyama, S. Toyooka, K.O. Toyooka, K. Harada, A.K. Virmani, and S. Zochbauer-Muller Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features Cancer Res. 61 2001 8659 8663
-
(2001)
Cancer Res.
, vol.61
, pp. 8659-8663
-
-
Maruyama, R.1
Toyooka, S.2
Toyooka, K.O.3
Harada, K.4
Virmani, A.K.5
Zochbauer-Muller, S.6
-
30
-
-
8444253477
-
Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung
-
J.S. Kim, H. Kim, Y.M. Shim, J. Han, J. Park, and D.H. Kim Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung Carcinogenesis 25 2004 2165 2171
-
(2004)
Carcinogenesis
, vol.25
, pp. 2165-2171
-
-
Kim, J.S.1
Kim, H.2
Shim, Y.M.3
Han, J.4
Park, J.5
Kim, D.H.6
-
31
-
-
2942737264
-
Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer
-
H. Kim, Y.M. Kwon, J.S. Kim, H. Lee, J.H. Park, and Y.M. Shim Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer J. Clin. Oncol. 22 2004 2363 2370
-
(2004)
J. Clin. Oncol.
, vol.22
, pp. 2363-2370
-
-
Kim, H.1
Kwon, Y.M.2
Kim, J.S.3
Lee, H.4
Park, J.H.5
Shim, Y.M.6
-
32
-
-
2542571001
-
CpG methylation in the Fhit regulatory region: Relation to Fhit expression in murine tumors
-
S.Y. Han, D. Iliopoulos, T. Druck, G. Guler, C.J. Grubbs, and M. Pereira CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors Oncogene 23 2004 3990 3998
-
(2004)
Oncogene
, vol.23
, pp. 3990-3998
-
-
Han, S.Y.1
Iliopoulos, D.2
Druck, T.3
Guler, G.4
Grubbs, C.J.5
Pereira, M.6
-
33
-
-
21744451774
-
Hypermethylation patterns in the Fhit regulatory region are tissue specific
-
G. Guler, D. Iliopoulos, S.Y. Han, L.Y. Fong, R.A. Lubet, C.J. Grubbs, K. Huebner, Hypermethylation patterns in the Fhit regulatory region are tissue specific, Mol. Carcinog. 3 (2005) 175-181.
-
(2005)
Mol. Carcinog.
, vol.3
, pp. 175-181
-
-
Guler, G.1
Iliopoulos, D.2
Han, S.Y.3
Fong, L.Y.4
Lubet, R.A.5
Grubbs, C.J.6
Huebner, K.7
-
34
-
-
4243814642
-
The tumor spectrum in FHIT-deficient mice
-
N. Zanesi, V. Fidanza, L.Y. Fong, R. Mancini, T. Druck, and M. Valtieri The tumor spectrum in FHIT-deficient mice Proc. Natl. Acad. Sci. USA 98 2001 10250 10255
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 10250-10255
-
-
Zanesi, N.1
Fidanza, V.2
Fong, L.Y.3
Mancini, R.4
Druck, T.5
Valtieri, M.6
-
35
-
-
0035930112
-
Potential cancer therapy with the fragile histidine triad gene: Review of the preclinical studies
-
H. Ishii, K.R. Dumon, A. Vecchione, L.Y. Fong, R. Baffa, K. Huebner, and C.M. Croce Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies J. Am. Med. Assoc. 19 2001 2441 2449
-
(2001)
J. Am. Med. Assoc.
, vol.19
, pp. 2441-2449
-
-
Ishii, H.1
Dumon, K.R.2
Vecchione, A.3
Fong, L.Y.4
Baffa, R.5
Huebner, K.6
Croce, C.M.7
-
36
-
-
8444235237
-
Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant
-
M. Ottey, S.Y. Han, T. Druck, B.L. Barnoski, K.A. McCorkell, and C.M. Croce Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant Br. J. Cancer 9 2004 1669 1677
-
(2004)
Br. J. Cancer
, vol.9
, pp. 1669-1677
-
-
Ottey, M.1
Han, S.Y.2
Druck, T.3
Barnoski, B.L.4
McCorkell, K.A.5
Croce, C.M.6
-
37
-
-
11144284736
-
Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway
-
B. Hu, S.Y. Han, X. Wang, M. Ottey, M.B. Potoczek, and A. Dicker Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway J. Cell Physiol. 202 2005 518 523
-
(2005)
J. Cell Physiol.
, vol.202
, pp. 518-523
-
-
Hu, B.1
Han, S.Y.2
Wang, X.3
Ottey, M.4
Potoczek, M.B.5
Dicker, A.6
-
38
-
-
11544354950
-
Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit
-
H.C. Pace, P.N. Garrison, A.K. Robinson, L.D. Barnes, A. Draganescu, and A. Rosler Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit Proc. Natl. Acad. Sci. USA 95 1998 5484 5489
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 5484-5489
-
-
Pace, H.C.1
Garrison, P.N.2
Robinson, A.K.3
Barnes, L.D.4
Draganescu, A.5
Rosler, A.6
-
39
-
-
1642329754
-
Fhit is a physiological target of the protein kinase Src
-
Y. Pekarsky, P.N. Garrison, A. Palamarchuk, N. Zanesi, R.I. Aqeilan, and K. Huebner Fhit is a physiological target of the protein kinase Src Proc. Natl. Acad. Sci. USA 101 2004 3775 3779
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 3775-3779
-
-
Pekarsky, Y.1
Garrison, P.N.2
Palamarchuk, A.3
Zanesi, N.4
Aqeilan, R.I.5
Huebner, K.6
-
40
-
-
0034655131
-
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer
-
A.K. Bednarek, K.J. Laflin, R.L. Daniel, Q. Liao, K.A. Hawkins, and C.M. Aldaz WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer Cancer Res. 60 2000 2140 2145
-
(2000)
Cancer Res.
, vol.60
, pp. 2140-2145
-
-
Bednarek, A.K.1
Laflin, K.J.2
Daniel, R.L.3
Liao, Q.4
Hawkins, K.A.5
Aldaz, C.M.6
-
41
-
-
0344100087
-
WWOX, the common chromosomal fragile site, FRA16D, cancer gene
-
J.H. Ludes-Meyers, A.K. Bednarek, N.C. Popescu, M. Bedford, and C.M. Aldaz WWOX, the common chromosomal fragile site, FRA16D, cancer gene Cytogenet. Genome Res. 100 2003 101 110
-
(2003)
Cytogenet. Genome Res.
, vol.100
, pp. 101-110
-
-
Ludes-Meyers, J.H.1
Bednarek, A.K.2
Popescu, N.C.3
Bedford, M.4
Aldaz, C.M.5
-
42
-
-
0035890419
-
FRA16D gene, behaves as a suppressor of tumor growth
-
A.K. Bednarek, C.L. Keck-Waggoner, R.L. Daniel, K. Laflin, P. Bergsagel, and K. Kiguchi FRA16D gene, behaves as a suppressor of tumor growth Cancer Res. 61 2001 8068 8073
-
(2001)
Cancer Res.
, vol.61
, pp. 8068-8073
-
-
Bednarek, A.K.1
Keck-Waggoner, C.L.2
Daniel, R.L.3
Laflin, K.4
Bergsagel, P.5
Kiguchi, K.6
-
43
-
-
0034654513
-
A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D
-
A.J. Paige, K.J. Taylor, A. Stewart, J.G. Sgouros, H. Gabra, and G.C. Sellar A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D Cancer Res. 60 2000 1690 1697
-
(2000)
Cancer Res.
, vol.60
, pp. 1690-1697
-
-
Paige, A.J.1
Taylor, K.J.2
Stewart, A.3
Sgouros, J.G.4
Gabra, H.5
Sellar, G.C.6
-
44
-
-
0034654641
-
Chromosomal fragile site FRA16D and DNA instability in cancer
-
M. Mangelsdorf, K. Ried, E. Woollatt, S. Dayan, H. Eyre, and M. Finnis Chromosomal fragile site FRA16D and DNA instability in cancer Cancer Res. 60 2000 1683 1689
-
(2000)
Cancer Res.
, vol.60
, pp. 1683-1689
-
-
Mangelsdorf, M.1
Ried, K.2
Woollatt, E.3
Dayan, S.4
Eyre, H.5
Finnis, M.6
-
45
-
-
0035890419
-
FRA16D gene, behaves as a suppressor of tumor growth
-
A.K. Bednarek, C.L. Keck-Waggoner, R.L. Daniel, K.J. Laflin, P.L. Bergsagel, and K. Kiguchi FRA16D gene, behaves as a suppressor of tumor growth Cancer Res. 61 2001 8068 8073
-
(2001)
Cancer Res.
, vol.61
, pp. 8068-8073
-
-
Bednarek, A.K.1
Keck-Waggoner, C.L.2
Daniel, R.L.3
Laflin, K.J.4
Bergsagel, P.L.5
Kiguchi, K.6
-
46
-
-
1842581808
-
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma
-
G. Guler, A. Uner, N. Guler, S.Y. Han, D. Iliopoulos, and W.W. Hauck The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma Cancer 8 2004 1605 1614
-
(2004)
Cancer
, vol.8
, pp. 1605-1614
-
-
Guler, G.1
Uner, A.2
Guler, N.3
Han, S.Y.4
Iliopoulos, D.5
Hauck, W.W.6
-
47
-
-
84888801206
-
Frequent loss of WWOX expression in breast cancer: Correlation with estrogen receptor status
-
M.I. Nunez, J. Ludes-Meyers, M.C. Abba, H. Kil, N. Abbey, and R.E. Page Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status Breast Cancer Res. Treat. 7 2005 32 1614
-
(2005)
Breast Cancer Res. Treat.
, vol.7
, pp. 32-1614
-
-
Nunez, M.I.1
Ludes-Meyers, J.2
Abba, M.C.3
Kil, H.4
Abbey, N.5
Page, R.E.6
-
48
-
-
20144372911
-
Fragile genes as biomarkers: Epigenetic control of WWOX and FHIT in lung, breast and bladder cancer
-
D. Iliopoulos, G. Guler, S.Y. Han, D. Johnston, T. Druck, and K.A. McCorkell Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer Oncogene 9 2005 1625 1633
-
(2005)
Oncogene
, vol.9
, pp. 1625-1633
-
-
Iliopoulos, D.1
Guler, G.2
Han, S.Y.3
Johnston, D.4
Druck, T.5
McCorkell, K.A.6
-
49
-
-
17144405305
-
Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites
-
H. Ishii, K. Mimor, T. Inageta, Y. Murakumo, A. Vecchione, M. Mori, and Y. Furukawa Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites Mol. Cancer Res. 3 2005 130 138
-
(2005)
Mol. Cancer Res.
, vol.3
, pp. 130-138
-
-
Ishii, H.1
Mimor, K.2
Inageta, T.3
Murakumo, Y.4
Vecchione, A.5
Mori, M.6
Furukawa, Y.7
-
50
-
-
11144354718
-
The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis
-
T. Kuroki, S. Yendamuri, F. Trapasso, A. Matsuyama, R.I. Aqeilan, and H. Alder The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis Clin. Cancer Res. 10 2004 2459 2465
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 2459-2465
-
-
Kuroki, T.1
Yendamuri, S.2
Trapasso, F.3
Matsuyama, A.4
Aqeilan, R.I.5
Alder, H.6
-
51
-
-
0037138411
-
WW and SH3 domains, two different scaffolds to recognize proline-rich ligands
-
M.J. Macias WW and SH3 domains, two different scaffolds to recognize proline-rich ligands FEBS Lett. 513 2002 30 37
-
(2002)
FEBS Lett.
, vol.513
, pp. 30-37
-
-
MacIas, M.J.1
-
52
-
-
0036157980
-
The WW domain: Linking cell signalling to the membrane cytoskeleton
-
J.L. Ilsley, M. Sudol, and S.J. Winder The WW domain: linking cell signalling to the membrane cytoskeleton Cell signaling 14 2002 183 189
-
(2002)
Cell Signaling
, vol.14
, pp. 183-189
-
-
Ilsley, J.L.1
Sudol, M.2
Winder, S.J.3
-
53
-
-
0033628253
-
Steroid dehydrogenase structures, mechanism of action, and disease
-
W.L. Duax, D. Ghosh, and V. Pletnev Steroid dehydrogenase structures, mechanism of action, and disease Vitam Horm. 58 2000 121 148
-
(2000)
Vitam Horm.
, vol.58
, pp. 121-148
-
-
Duax, W.L.1
Ghosh, D.2
Pletnev, V.3
-
54
-
-
13244271314
-
17beta-Estradiol up-regulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: Potential role in cancerous progression of breast and prostate to a premetastatic state in vivo
-
N.S. Chang, L. Schultz, L.J. Hsu, J. Lewis, M. Su, and C.I. Sze 17beta-Estradiol up-regulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo Oncogene 24 2005 714 723
-
(2005)
Oncogene
, vol.24
, pp. 714-723
-
-
Chang, N.S.1
Schultz, L.2
Hsu, L.J.3
Lewis, J.4
Su, M.5
Sze, C.I.6
-
55
-
-
3042784091
-
The specific proline-rich ligand PPXY: Identification of candidate interacting proteins
-
J.H. Ludes-Meyers, H. Kil, A.K. Bednarek, J. Drake, M. Bedford, C.M. Aldaz, and W.W.O.X. binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins Oncogene 23 2004 5049 5055
-
(2004)
Oncogene
, vol.23
, pp. 5049-5055
-
-
Ludes-Meyers, J.H.1
Kil, H.2
Bednarek, A.K.3
Drake, J.4
Bedford, M.5
Aldaz, C.M.6
Binds, W.W.O.X.7
-
56
-
-
12144289659
-
Functional association between Wwox tumor suppressor protein and p73, a p53 homolog
-
R.I. Aqeilan, Y. Pekarsky, J.J. Herrero, A. Palamarchuk, J. Letofsky, and T. Druck Functional association between Wwox tumor suppressor protein and p73, a p53 homolog Proc. Natl. Acad. Sci. USA 101 2004 4401 4406
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 4401-4406
-
-
Aqeilan, R.I.1
Pekarsky, Y.2
Herrero, J.J.3
Palamarchuk, A.4
Letofsky, J.5
Druck, T.6
-
57
-
-
8544283814
-
Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor
-
R.I. Aqeilan, A. Palamarchuk, R.J. Weigel, J.J. Herrero, Y. Pekarsky, and C.M. Croce Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor Cancer Res. 64 2004 8256 8266
-
(2004)
Cancer Res.
, vol.64
, pp. 8256-8266
-
-
Aqeilan, R.I.1
Palamarchuk, A.2
Weigel, R.J.3
Herrero, J.J.4
Pekarsky, Y.5
Croce, C.M.6
|